Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Lenka Ostřížková"'
Autor:
Andrea Šprláková-Puková, Hana Petrášová, Alexandra Litavcová, Zdeněk Kala, Lenka Ostřížková, Marek Dostál
Publikováno v:
Onkologie. 17:31-34
Autor:
Jan Zavadil, Tomáš Rohan, Jaroslav Juráček, Igor Kiss, Lenka Ostřížková, Vlastimil Válek, Ondřej Slabý, Tomáš Andrašina
Publikováno v:
Klinicka onkologie. 36
Autor:
Ondřej Slabý, Kateřina Nevědělová, Igor Kiss, Veronika Zubáňová, Zdeněk Kala, Zuzana Tylichová, Jana Nekvindová, Jan Vondráček, Alena Hyršlová Vaculová, Lucia Bohovicova, Pavel Fabian, Martin Krkoška, Petr Kysela, Jarmila Herůdková, Lenka Ostřížková, Vladimir Palicka, Lenka Radová
Publikováno v:
Pharmacological Reports. 74:148-158
Background Hepatocellular carcinoma (HCC) is a major contributor to the worldwide cancer burden. Recent studies on HCC have demonstrated dramatic alterations in expression of several cytochrome P450 (CYP) family members that play a crucial role in bi
Autor:
Lenka Ostřížková
Publikováno v:
Onkologie. 14:258-261
Autor:
Jan Hlavsa, Jiří Mayer, Zdeněk Kala, Ivana Kosíková, Ondřej Slabý, Dagmar Brančíková, Lenka Ostřížková, Pavel Janeček, Lumír Kunovský, Michal Eid, Monika Blažková
Publikováno v:
Neoplasma. 68:1-9
Pancreatic ductal adenocarcinoma (PDAC) is now the 11th most common cancer and in 2018 there were 458,918 new cases worldwide. In the Czech Republic, a total of 2,173 patients were diagnosed in 2015, ranking the second in incidence worldwide. In cont
Autor:
Martin, Krkoška, Jana, Nekvindová, Kateřina, Nevědělová, Veronika, Zubáňová, Lenka, Radová, Jan, Vondráček, Jarmila, Herůdková, Ondřej, Slabý, Igor, Kiss, Lucia, Bohovicová, Pavel, Fabian, Zuzana, Tylichová, Zdeněk, Kala, Petr, Kysela, Lenka, Ostřížková, Vladimír, Palička, Alena, Hyršlová Vaculová
Publikováno v:
Pharmacological reports : PR. 74(1)
Hepatocellular carcinoma (HCC) is a major contributor to the worldwide cancer burden. Recent studies on HCC have demonstrated dramatic alterations in expression of several cytochrome P450 (CYP) family members that play a crucial role in biotransforma
Autor:
Beáta Hemmelová, Martin Zatloukal, Vladimír Čan, Šárka Bohatá, Pavel Šlampa, Marek Svoboda, Lenka Ostřížková, Zdeněk Kala, Ondřej Slabý
Publikováno v:
Klinicka Onkologie.
BACKGROUND Rectal cancer treatment advanced rapidly during last decades. The most important factors of this progress are new neoadjuvant therapy options, improvement in imaging (allowing for quality staging and restaging) and routine implementation o
Prognostic Survival Factors of Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
Autor:
Tomáš, Rohan, Michal, Uher, Peter, Matkulčík, Jan, Zavadil, Lenka, Ostřížková, Igor, Kiss, Tomáš, Andrašina, Vlastimil, Válek
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 33(3)
Identification of prognostic survival factors of hepatocellular carcinoma (HCC) treated with transarterial chemoembolization (TACE) in a single center in 2005-2018.Transarterial chemoembolization in hepatocellular carcinoma is indicated in Barcelona
Autor:
Zdeněk Král, Lenka Ostřížková, Dagmar Brančíková, Tomáš Nebeský, Luděk Pour, Jiří Mayer, Zdeněk Adam
Publikováno v:
Vnitřní lékařství. 63:672-678
Angiomatosis is a term for multiple, gradually proliferating hemangiomas (angiodysplasia), affecting multiple organs or tissues at the same time. We describe a 12-year course of treatment of a patient with multiple hemangiomas located in the abdomen,
Autor:
Viera Sandecká, Lenka Ostřížková, Jan Straub, Zdeněk Adam, Dagmar Brančíková, Martin Stork, Marta Krejčí, Luděk Pour
Publikováno v:
Vnitřní lékařství. 63:311-321
Bisphosphonates have been used during the complete treatment of multiple myeloma for more than twenty years. They slow osteolysis and thereby contribute to the improvement of quality of life. Their long-term use, however, is related to 2 serious, usu